Fresenius News (NYSE:FMS)

DateTimeSource
Headline
06/20/20179:30AMBWFrenova Renal Research Announces Expansion of F1RST Up™ (Frenova Rapid STart Up) Alliance of Investigative Sites Designed t...
Membership Climbs to 55 Renal Investigators Representing 23 Research Sites Frenova Renal Research, the world’s only drug and medical device contract clinical development services provider dedicated exclusively to renal research, today announced that its F1RST Up™ alliance of clinical research sites focusing on kidney... More...>>
04/28/201710:44AMDJNFresenius Medical Care 1Q 2017 -- Forecast
FRANKFURT--The following is a summary of analysts' forecasts for Fresenius Medical Care AG & Co. KGaA (FMS) first-quarter results (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released May 3. === Forecast Change Reported 1st Quarter... More...>>
04/20/201710:22AMBWFresenius Medical Care North America Announces Kidney Walk National Team in Support of the National Kidney Foundation
Fresenius Medical Care North America (FMCNA), the nation’s leading renal care company, announces a company-wide national team in support of the National Kidney Foundation’s (NKF) annual Kidney Walk, the nation's largest fundraiser to fight kidney disease. By bringing together the collective power of Fresenius Medical... More...>>
04/13/20178:36AMBWNew President of FreseniusRx to Build on Company’s Success in Contributing to Positive Patient Outcomes
RJ Correia takes the helm as FreseniusRx’s pharmacy customers experience improved health measurements FreseniusRx, a nationwide pharmacy focused on medication access and adherence for patients on dialysis, announced today that it has named Randell (RJ) Correia, PharmD, as its new President. In this role, Correia will... More...>>
04/12/20175:30AMBWフレゼニウス メディカル ケアがフォーム20-Fの2016会計年度報告書を公表
(ビジネスワイヤ) 透析用製品/サービスを提供する世界最大企業のフレゼニウス メディカル ケア(「当社」または「フレゼニウス メディカル ケア」)は本日、フォーム20-Fに基づく2016年度年次報告書を米国証券取引委員会(SEC)に提出したと発表しました。本報告書は当社のウェブサイト(www.freseniusmedicalcare.com)の「投資家」セクションに加え、SECのウェブサイト(www.sec.gov)でご覧いただけます。... More...>>
04/10/201710:42AMBWFresenius Medical Care AG & Co. KGaA a publié un formulaire 20-F pour l’exercice 2016
Fresenius Medical Care AG & Co. KGaA (« la société » ou « Fresenius Medical Care »), le plus important fournisseur mondial de produits et services de dialyse, a annoncé avoir déposé son rapport annuel 2016 sur formulaire 20-F auprès de la Commission américaine des opérations de Bourse (la « SEC »). Le... More...>>
04/10/20178:02AMBWFresenius Medical Care AG & Co. KGaA veröffentlicht Formblatt 20-F für das Geschäftsjahr 2016
Die Fresenius Medical Care AG & Co. KGaA („das Unternehmen“ oder „Fresenius Medical Care“), der weltweit größte Anbieter von Dialyseprodukten und -dienstleistungen, teilte mit, dass sie den Jahresbericht 2016 auf Formblatt 20-F bei der US-amerikanischen Börsenaufsicht Securities and Exchange Commission (SEC... More...>>
04/10/20174:53AMBWFresenius Medical Care AG & Co. KGaA Published Form 20-F for the Fiscal Year 2016
Fresenius Medical Care AG & Co. KGaA ("the company" or "Fresenius Medical Care"), the world's largest provider of dialysis products and services, announced that it has filed the annual report 2016 under form 20-F with the U.S. Securities and Exchange Commission (SEC). The report is available at the company's website... More...>>
03/16/20173:13PMBWFMCNA’s Acumen Physician Solutions Division Unveils Acumen 2.0, Powered by Epic
Acumen Physician Solutions, a subsidiary of Fresenius Medical Care North America (FMCNA), today announced that it has joined forces with Epic Systems Corporation to develop Acumen 2.0 powered by Epic. This unprecedented partnership between the nation’s two largest providers of electronic health records (EHRs) for nephrologists... More...>>
03/09/20178:30AMBWFresenius Medical Care and Humana Partner to Improve Health of Kidney Failure Patients Across the Nation
Fresenius Medical Care North America (FMCNA), a division of Fresenius Medical Care (NYSE: FMS), announced today that it is joining forces with Humana Inc. (NYSE: HUM) in a new program designed to improve care and health outcomes for Humana’s members with end stage renal disease (ESRD). This Smart News Release features... More...>>
02/22/20172:12AMDJNFresenius Profit Lifted by Strong U.S. Performance
By William Wilkes FRANKFURT--German healthcare company Fresenius SE (FRE.XE) said Wednesday that revenue and profit rose in the fourth quarter, helped by firm U.S. sales. In the three months through December, Fresenius' revenue increased 7% to 7.7 billion euros ($8.12 billion), with sales in North America rising around... More...>>
02/20/201710:30AMDJNFresenius Medical Care AG & Co. KGaA 4Q 2016 -- Forecast
FRANKFURT--The following is a summary of analysts' forecasts for Fresenius Medical Care AG & Co. KGaA (FMS) fourth-quarter results, based on a poll of four analysts conducted by Dow Jones Newswires (figures in million dollars, EPS in dollar, dividend and target price in euro, according to US-GAAP). Earnings figures... More...>>
01/25/20179:07PMDJNJudge Blocks Rule That Would Limit Premium Assistance for Dialysis Patients
By Anna Wilde Mathews A judge blocked a federal rule that was expected to limit dialysis providers' ability to help patients pay for individual insurance plans. U.S. District Judge Amos Mazzant, in Sherman, Texas, issued an order delaying the rule indefinitely while he hears a suit opposing it filed by major dialysis... More...>>
01/19/20178:30AMBWFresenius Medical Care Uniquely Positioned to Transform Care for Kidney Failure Patients as Primary Participant in National M...
Centers for Medicare & Medicaid Services Awards 18 End Stage Renal Disease Seamless Care Organizations to Fresenius Medical Care, the Largest ESCO Operator in the United States Fresenius Medical Care North America, the country’s leading provider of kidney care products and services, announced today that the Centers... More...>>
01/12/201711:38PMBWStatement of Fresenius Medical Care North America Regarding U.S. Court Ruling Granting Temporary Restraining Order
In response to the U.S. District Court’s ruling today granting a temporary restraining order regarding charitable contributions for premium assistance, Fresenius Medical Care North America issued the following statement: “Following a hearing earlier today, United States District Judge Amos L. Mazzant of the Eastern... More...>>
01/12/201710:32PMDJNJudge Blocks Rule That Could Limit Premium Assistance for Dialysis Patients
By Anna Wilde Mathews A judge blocked a federal rule that was expected to limit dialysis providers' ability to help patients pay for individual insurance plans, which was set to go into effect Friday. U.S. District Judge Amos Mazzant, in Sherman, Texas, issued a temporary restraining order delaying the rule by two... More...>>
01/09/20177:51PMBWIMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Fresenius Medical Care AG & Co. KGAA & Advises Invest...
Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating Fresenius Medical Care AG & Co. KGAA (“Fresenius” or the “Company”) (NYSE: FMS) concerning possible violations of federal securities laws. If you are a shareholder who suffered a loss during the Class Period... More...>>
01/09/20175:50PMBWGlancy Prongay & Murray LLP Commences Investigation on Behalf of Fresenius Medical Care AG & Co. KGAA Investors
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Fresenius Medical Care AG & Co. KGAA (“Fresenius” or the “Company”) (NYSE: FMS) investors concerning the Company and its officers’ possible violations of federal securities laws. GPM is preparing a lawsuit on behalf of Fresenius... More...>>
01/09/20174:00PMBWEQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Fresenius Medical Care AG & Co. KGAA - FMS
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Fresenius Medical Care AG & Co. KGAA (NYSE: FMS) resulting from allegations that Fresenius may have issued materially misleading business information to the investing public. On... More...>>
01/09/20171:41PMPRNUSSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Fresenius Medical Care AG & Co. KGAA (FMS)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Fresenius Medical Care AG & Co. KGAA (FMS) PR Newswire NEW YORK, Jan. 9, 2017 NEW YORK, Jan. 9, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V:us D:20170624 15:39:46